Can we use the tools we already have to help patients in need? Evaluating practice-based evidence of analgesic effects from intermittent theta burst stimulation for treatment of de... by P. Maxwell Slepian

Get full text

Development of next generation sequencing panel for UMOD and association with kidney disease. by Caitlin Bailie, Jill Kilner, Alexander P Maxwell, Amy Jayne McKnight

Get full text

Bioinformatic Evaluation of Transcriptional Regulation of WNT Pathway Genes with reference to Diabetic Nephropathy by Gareth J. McKay, David H. Kavanagh, John K. Crean, Alexander P. Maxwell

Get full text

The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review. by Sarah Elshahat, Paul Cockwell, Alexander P Maxwell, Matthew Griffin, Timothy O'Brien, Ciaran O'Neill

Get full text

Phenotypic Changes in Mitochondrial Membrane Potential (Δψm) during Valinomycin-Induced Depolarisation and Apoptosis by M. L. Morrison, K. Williamson, K. Arthur, G. J. Price, P. W. Hamilton, P. Maxwell

Get full text

Duke activity status index is not predictive of outcomes after kidney transplantation: a retrospective observational study by Ruth Fergie, Alexander P. Maxwell, Aisling E. Courtney, Michael Corr, Stephen O’Neill, Emma L. Cunningham

Get full text

Systematic review of the application of the Kidney Failure Risk Equation and Oxford classification in estimating prognosis in IgA Nephropathy by M. P. Toal, R. Fergie, M. P. Quinn, C. J. Hill, C. O’Neill, A. P. Maxwell

Get full text

The effect of tranexamic acid on blood coagulation in primary total hip arthroplasty using rotational thromboelastometry: a randomized controlled trialResearch in context by Uzung Yoon, David Beausang, Elia Elia, Marc Torjman, Jeffrey Mojica, James Purtill, David Nazarian, P. Maxwell Courtney, Yoogoo Kang

Get full text

Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL2 and HDL3 by Kayleigh Griffiths, Agnieszka Pazderska, Mohammed Ahmed, Anne McGowan, Alexander P. Maxwell, Jane McEneny, James Gibney, Gareth J. McKay

Get full text

An automated software algorithm for optimizing microwave ablation parameters for treatment of liver tumors by Sabrina Q. R. Liew, Nathaniel Rex, Celina Hsieh, Hyeonseon Kim, Scott A. Collins, Grayson L. Baird, DaeHee Kim, Aaron W. P. Maxwell

Get full text

Mesenchymal stromal cell therapy compared to SGLT2-inhibitors and usual care in treating diabetic kidney disease: A cost-effectiveness analysis. by Luke E Barry, Grainne E Crealey, Paul Cockwell, Stephen J Elliman, Matthew D Griffin, Alexander P Maxwell, Timothy O'Brien, Norberto Perico, Ciaran O'Neill

Get full text

Association analysis of dyslipidemia-related genes in diabetic nephropathy. by Gareth J McKay, David A Savage, Christopher C Patterson, Gareth Lewis, Amy Jayne McKnight, Alexander P Maxwell, Warren 3/UK GoKinD Study Group

Get full text

TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers by Kimberly J. Briggs, Kevin M. Cottrell, Matthew R. Tonini, Alice Tsai, Minjie Zhang, Douglas A. Whittington, Wenhai Zhang, Steven A. Lombardo, Satoshi Yoda, Erik W. Wilker, Samuel R. Meier, Yi Yu, Teng Teng, Alan Huang, John P. Maxwell

Get full text

Donor and Recipient Polygenic Risk Scores Influence Kidney Transplant Function by Kane E. Collins, Kane E. Collins, Kane E. Collins, Edmund Gilbert, Edmund Gilbert, Vincent Mauduit, Katherine A. Benson, Katherine A. Benson, Elhussein A. E. Elhassan, Elhussein A. E. Elhassan, Conall O’Seaghdha, Conall O’Seaghdha, Claire Hill, Amy Jayne McKnight, Alexander P. Maxwell, Peter J. van der Most, Martin H. de Borst, Weihua Guan, Pamala A. Jacobson, Ajay K. Israni, Brendan J. Keating, Graham M. Lord, Salla Markkinen, Ilkka Helanterä, Kati Hyvärinen, Jukka Partanen, Stephen F. Madden, Matthew B. Lanktree, Sophie Limou, Gianpiero L. Cavalleri, Gianpiero L. Cavalleri, Gianpiero L. Cavalleri, Peter J. Conlon, Peter J. Conlon

Get full text

New susceptibility loci associated with kidney disease in type 1 diabetes. by Niina Sandholm, Rany M Salem, Amy Jayne McKnight, Eoin P Brennan, Carol Forsblom, Tamara Isakova, Gareth J McKay, Winfred W Williams, Denise M Sadlier, Ville-Petteri Mäkinen, Elizabeth J Swan, Cameron Palmer, Andrew P Boright, Emma Ahlqvist, Harshal A Deshmukh, Benjamin J Keller, Huateng Huang, Aila J Ahola, Emma Fagerholm, Daniel Gordin, Valma Harjutsalo, Bing He, Outi Heikkilä, Kustaa Hietala, Janne Kytö, Päivi Lahermo, Markku Lehto, Raija Lithovius, Anne-May Osterholm, Maija Parkkonen, Janne Pitkäniemi, Milla Rosengård-Bärlund, Markku Saraheimo, Cinzia Sarti, Jenny Söderlund, Aino Soro-Paavonen, Anna Syreeni, Lena M Thorn, Heikki Tikkanen, Nina Tolonen, Karl Tryggvason, Jaakko Tuomilehto, Johan Wadén, Geoffrey V Gill, Sarah Prior, Candace Guiducci, Daniel B Mirel, Andrew Taylor, S Mohsen Hosseini, DCCT/EDIC Research Group, Hans-Henrik Parving, Peter Rossing, Lise Tarnow, Claes Ladenvall, François Alhenc-Gelas, Pierre Lefebvre, Vincent Rigalleau, Ronan Roussel, David-Alexandre Tregouet, Anna Maestroni, Silvia Maestroni, Henrik Falhammar, Tianwei Gu, Anna Möllsten, Danut Cimponeriu, Mihai Ioana, Maria Mota, Eugen Mota, Cristian Serafinceanu, Monica Stavarachi, Robert L Hanson, Robert G Nelson, Matthias Kretzler, Helen M Colhoun, Nicolae Mircea Panduru, Harvest F Gu, Kerstin Brismar, Gianpaolo Zerbini, Samy Hadjadj, Michel Marre, Leif Groop, Maria Lajer, Shelley B Bull, Daryl Waggott, Andrew D Paterson, David A Savage, Stephen C Bain, Finian Martin, Joel N Hirschhorn, Catherine Godson, Jose C Florez, Per-Henrik Groop, Alexander P Maxwell

Get full text